Its sort of an interesting aspect of looking at heart disease from the TMAO metabolites in the gut, which come from fish, unfortunately
T.BuenafeA.et al (2021a)
Disclosures: Ai-Thien Do: Nothing to Disclose, Ming-Lung Yu: Abbvie, Gilead and Roche diagnostics.: Grant/Research Support, Abbott, Abbvie, Gilead, Roche and Roche diagnostics: Consultant, Abbvie, BMS, Gilead, Roche and Roche diagnostics: Speaking and Teaching, Hidenori Toyoda: Nothing to Disclose, Seng Gee Lim: Nothing to Disclose, Ramsey Cheung: Nothing to Disclose, Man-Fung Yuen: Nothing to Disclose, Yasuhito Tanaka: Nothing to Disclose, Wan Long Chuang: Gilead: Speaking and Teaching, AbbVie: Speaking and Teaching, BMS: Speaking and Teaching, Vaccitech: Consultant, PharmaEssentia: Consultant, Chao Wu: Nothing to Disclose, Maria Buti: Nothing to Disclose, Nothing to Disclose, Adrian Gadano: Nothing to Disclose, Ming-Lun Yeh: Nothing to Disclose, Chung-Feng Huang: Nothing to Disclose, Rui Huang: Nothing to Disclose, Jee-Fu Huang: Nothing to Disclose, Chia-Yen Dai: Nothing to Disclose, Mayumi Maeda: Nothing to Disclose, Kaori Inoue: Nothing to Disclose, Chul-Jin Lee: Nothing to Disclose, Cheng-Hao Tseng: Nothing to Disclose, Ana Barreira: Nothing to Disclose, Rex Wan-Hin Hui: Nothing to Disclose, Kwan-Lung Ko: Nothing to Disclose, Yoko Yoshimaru: Nothing to Disclose, Takanori Suzuki: Nothing to Disclose, Irina Sandra: Nothing to Disclose, Raluca Marin: Nothing to Disclose, Vy Nguyen: Nothing to Disclose, Yao-Chun Hsu: Gilead Sciences: Grant/Research Support, Gilead Sciences: Advisor, Sysmex: Advisor, Abbvie: Speaking and Teaching, Bristol Myers Squibb: Speaking and Teaching, Gilead Sciences: Speaking and Teaching, Roch: Speaking and Teaching, Huy Trinh: Nothing to Disclose, Jiayi Li: Nothing to Disclose, jianqing zhang: Nothing to Disclose, Eiichi Ogawa: Gilead Sciences: Grant/Research Support, Dong Hyun Lee: Nothing to Disclose, Takanori Ito: Chugai Pharmaceutical Co., Ltd.: Grant/Research Support, Chugai Pharmaceutical Co., Ltd
Blood Virome research in myalgic encephalomyelitis/chronic fatigue syndrome: challenges and opportunities
doi: 10.4103/ejpi.EJPI-D-24-00101 75
